1H, 13C and 15N backbone NMR chemical shift assignments of the C-terminal P4 domain of Ahnak

Article

Abstract

Ahnak is a ~ 700 kDa polypeptide that was originally identified as a tumour-related nuclear phosphoprotein, but later recognized to play a variety of diverse physiological roles related to cell architecture and migration. A critical function of Ahnak is modulation of Ca2+ signaling in cardiomyocytes by interacting with the β subunit of the L-type Ca2+ channel (CaV1.2). Previous studies have identified the C-terminal region of Ahnak, designated as P3 and P4 domains, as a key mediator of its functional activity. We report here the nearly complete 1H, 13C and 15N backbone NMR chemical shift assignments of the 11 kDa C-terminal P4 domain of Ahnak. This study lays the foundations for future investigations of functional dynamics, structure determination and interaction site mapping of the CaV1.2-Ahnak complex.

Keywords

Ahnak NMR Resonance assignments Circular dichroism Chemical shift index CaV1.2 modulation 

Notes

Acknowledgements

This work was supported by Grant APP1126201 from the Australian National Health and Medical Research Council (NHMRC) to MGC. The study made use of the NMR facility at the Research School of Chemistry at the Australian National University. The authors would like to thank Ms Elmira Bahraminejad for help with the circular dichroism spectroscopy.

Compliance with ethical standards

Conflict of interest

The authors declare no conflict of interest.

References

  1. Alvarez J, Hamplova J, Hohaus A, Morano I, Haase H, Vassort G (2004) Calcium current in rat cardiomyocytes is modulated by the carboxyl-terminal Ahnak domain. J Biol Chem 279:12456–12461.  https://doi.org/10.1074/jbc.M312177200 CrossRefGoogle Scholar
  2. Benaud C, Gentil BJ, Assard N, Court M, Garin J, Delphin C, Baudier J (2004) Ahnak interaction with the annexin 2/S100A10 complex regulates cell membrane cytoarchitecture. J Cell Biol 164:133–144.  https://doi.org/10.1083/jcb.200307098 CrossRefGoogle Scholar
  3. Chemes LB, Alonso LG, Noval MG, de Prat-Gay G (2012) Circular dichroism techniques for the analysis of intrinsically disordered proteins and domains. In: Uversky VN, Dunker AK (eds) Intrinsically disordered protein analysis: volume 1, methods and experimental tools. Humana Press, Totowa, NJ, pp 387–404.  https://doi.org/10.1007/978-1-61779-927-3_22 CrossRefGoogle Scholar
  4. Cheung M-S, Maguire ML, Stevens TJ, Broadhurst RW (2010) DANGLE: a Bayesian inferential method for predicting protein backbone dihedral angles and secondary structure. J Magn Reson 202:223–233.  https://doi.org/10.1016/j.jmr.2009.11.008 ADSCrossRefGoogle Scholar
  5. Davis TA, Loos B, Engelbrecht A-M (2014) AHNAK: the giant jack of all trades. Cell Signal 26:2683–2693.  https://doi.org/10.1016/j.cellsig.2014.08.017 CrossRefGoogle Scholar
  6. Haase H (2007) Ahnak, a new player in β-adrenergic regulation of the cardiac L-type Ca2+ channel. Cardiovasc Res 73:19–25.  https://doi.org/10.1016/j.cardiores.2006.09.001 CrossRefGoogle Scholar
  7. Hohaus A, Person V, Behlke J, Schaper J, Morano I, Haase H (2002) The carboxyl-terminal region of ahnak provides a link between cardiac L-type Ca2+ channels and the actin-based cytoskeleton. FASEB J 16:1205–1216.  https://doi.org/10.1096/fj.01-0855com CrossRefGoogle Scholar
  8. Huang Y, Laval SH, van Remoortere A, Baudier J, Benaud C, Anderson LVB, Straub V, Deelder A, Frants RR, den Dunnen JT, Bushby K, van der Maarel SM (2007) AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration. FASEB J 21:732–742.  https://doi.org/10.1096/fj.06-6628com CrossRefGoogle Scholar
  9. Lee IH, Sohn M, Lim HJ, Yoon S, Oh H, Shin S, Shin JH, Oh S-H, Kim J, Lee DK, Noh DY, Bae DS, Seong JK, Bae YS (2014) Ahnak functions as a tumor suppressor via modulation of TGFβ/Smad signaling pathway. Oncogene 33:4675–4684.  https://doi.org/10.1038/onc.2014.69 CrossRefGoogle Scholar
  10. Lim HJ, Kang DH, Lim JM, Kang DM, Seong JK, Kang SW, Bae YS (2013) Function of Ahnak protein in aortic smooth muscle cell migration through Rac activation. Cardiovasc Res 97:302–310.  https://doi.org/10.1093/cvr/cvs311 CrossRefGoogle Scholar
  11. Matza D, Badou A, Kobayashi KS, Goldsmith-Pestana K, Masuda Y, Komuro A, McMahon-Pratt D, Marchesi VT, Flavell RA (2008) A scaffold protein, AHNAK1, is required for calcium signaling during T cell activation. Immunity 28:64–74.  https://doi.org/10.1016/j.immuni.2007.11.020 CrossRefGoogle Scholar
  12. Nie Z, Hashimoto T, Ning W, Amagai M (2000) C-terminus of desmoyokin/AHNAK protein is responsible for its translocation between the nucleus and cytoplasm. J Investig Dermatol 114:1044–1049.  https://doi.org/10.1046/j.1523-1747.2000.00949.x CrossRefGoogle Scholar
  13. Shtivelman E, Bishop JM (1993) The human gene AHNAK encodes a large phosphoprotein located primarily in the nucleus. J Cell Biol 120:625–630.  https://doi.org/10.1083/jcb.120.3.625 CrossRefGoogle Scholar
  14. Shtivelman E, Cohen FE, Bishop JM (1992) A human gene (AHNAK) encoding an unusually large protein with a 1.2-microns polyionic rod structure. Proc Natl Acad Sci USA 89:5472–5476.  https://doi.org/10.1073/pnas.89.12.5472 ADSCrossRefGoogle Scholar
  15. Sussman J, Stokoe D, Ossina N, Shtivelman E (2001) Protein kinase B phosphorylates AHNAK and regulates its subcellular localization. J Cell Biol 154:1019–1030.  https://doi.org/10.1083/jcb.200105121 CrossRefGoogle Scholar
  16. Vranken WF, Boucher W, Stevens TJ, Fogh RH, Pajon A, Llinas M, Ulrich EL, Markley JL, Ionides J, Laue ED (2005) The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins 59:687–696.  https://doi.org/10.1002/prot.20449 CrossRefGoogle Scholar
  17. Whitmore L, Wallace BA (2004) DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic Acids Res 32:W668-W673.  https://doi.org/10.1093/nar/gkh371 Google Scholar
  18. Wishart DS, Sykes BD (1994) The 13C chemical-shift index: a simple method for the identification of protein secondary structure using 13C chemical-shift data. J Biomol NMR 4:171–180.  https://doi.org/10.1007/BF00175245 CrossRefGoogle Scholar
  19. Wishart DS, Bigam CG, Yao J, Abildgaard F, Dyson HJ, Oldfield E, Markley JL, Sykes BD (1995) 1H, 13C and 15N chemical shift referencing in biomolecular NMR. J Biomol NMR 6:135–140.  https://doi.org/10.1007/BF00211777 CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V., part of Springer Nature 2018

Authors and Affiliations

  1. 1.ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical ResearchThe Australian National UniversityCanberraAustralia

Personalised recommendations